April 24, 2020
– GlycoMimetics reports Q1 2020 results on May 1
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will host a conference call and webcast to report its…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 24, 2020
Lineage Cell Therapeutics sells $3.7M OncoCyte shares
announced the pricing of the sale of 1,672,689 shares of common stock of OncoCyte Corporation at a price to buyers of $2.27 per share, representing the closing price of OncoCyte common stock on April 23, 2020.
April 24, 2020
– BIO KOREA 2020 International convention virtual
CHEONGJU, South Korea–(BUSINESS WIRE)–#BIOKOREA—BIO KOREA 2020 International Convention, where global bio experts correspond, is shifting to an online-only event.
April 24, 2020
Positive outcome from study for Chugai’s satralizumab
Satralizumab monotherapy significantly reduced risk of relapse in patients with NMOSD, following a previous positive study where satralizumab was added to baseline immunosuppressant therapy.
April 24, 2020
Noxxon kicks off brain cancer patients recruitment
Noxxon Pharma said Friday that recruitment of patients in second cohort has been initiated for the middle dose cohort for the Phase 1/2 NOX-A12 plus radiotherapy brain cancer trial.
April 23, 2020
Sanofi’s brain-penetrant BTK inhibitor could reduce disability markers progression for people with MS
Sanofi believes its brain-penetrant BTK inhibitor shows promise for reducing both neuroinflammation and neurodegeneration, markers of disability progression in people living with MS.
April 22, 2020
Dev. Health issues interest settlement securities
QUÉBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on…
April 22, 2020
Ipsen Reports Solid Sales Growth in First Quarter 2020 With Limited COVID-19 Impact
Ipsen has continued momentum with Q1 2020 Group sales growth of 9.6% as reported, or 8.7% at constant exchange rates, while 2020 Guidance remains suspended as announced in March given the uncertainty around the duration and scale of the COVID-19 pandemic.
April 22, 2020
– Israel’s MigVax nets $12 million in investment round
MigVax is getting an investment of $12 million to accelerate path to clinical trials and bring Israel’s human coronavirus vaccine to market, as it pioneers the effort to develop Israel’s human vaccine against COVID-19.
April 22, 2020
Roche’s test to detect women at risk for cervical cancer gets FDA approval
Roche got approval from US Food and Drug Administration (FDA) for the cobas HPV test for use on the fully automated, high-throughput cobas 6800/8800 Systems which identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples.